Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong · Delayed Price · Currency is HKD 538.00
+5.00 (0.94%)
Aug 21, 2026, 4:08 PM HKT
HKG:6990 Market Cap
HKG:6990 has a market cap or net worth of 128.59 billion as of August 21, 2026. Its market cap has increased by 30.55% in one year.
Market Cap
128.59B
Enterprise Value
123.17B
Revenue
2.41B
Ranking
n/a
PE Ratio
736.64
Stock Price
538.00
ChartMarket Cap Chart
Since July 11, 2023, HKG:6990's market cap has increased from 13.49B to 128.59B, an increase of 853.31%. That is a compound annual growth rate of 106.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 128.59B | 40.61% |
| Dec 31, 2025 | 91.46B | 146.43% |
| Dec 31, 2024 | 37.11B | 64.54% |
| Dec 29, 2023 | 22.56B | 67.21% |
| Jul 11, 2023 | 13.49B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 335.97B |
| WuXi Biologics | 196.57B |
| Innovent Biologics | 171.05B |
| Sino Biopharmaceutical | 85.29B |
| Akeso | 82.26B |
| RemeGen | 69.08B |
| Genscript Biotech | 64.21B |
| Biocytogen Pharmaceuticals (Beijing) | 58.22B |